ClinicalTrials.gov
public full text
Public Domain
Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Prospectively Investigate the effectiveness and safety of anlotinib hydrochloride combined with Capeox in neoadjuvant treatment of patients with locally advanced rectal cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement#127589
- Adjuvant Therapy With Anlotinib for HCC#919107
- Role of Total Neoadjuvant Therapy in Non-Metastatic Mid and Low Rectal Cancer. Experience of the Medical Oncology Department at the Pierre and Marie Curie Center, Algiers#427369
- A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma#850949
- Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)#1350614
Record · ID 1184403
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive